NRNathalie Amara Reilly

Nathalie Amara Reilly

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nathalie Amara Reilly has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Bastiaan T. Heijmans

    Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.

    5 shared publications
  • Koen F. Dekkers

    Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands

    4 shared publications
  • J. Wouter Jukema

    Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands; Netherlands Heart Institute, Utrecht, the Netherlands

    3 shared publications
  • Marten A. Hoeksema

    Department of Medical Biochemistry, Amsterdam University Medical Center, University of Amsterdam, Amsterdam the Netherlands

    3 shared publications
  • Thomas B. Kuipers

    Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands; Sequencing Analysis Support Core, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands

    3 shared publications
  • Jeroen Molenaar

    Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands

    2 shared publications

Latest Publications

  • Open Access

    Triglycerides and T Cells in Cardiovascular Risk

    by Nathalie A. Reilly, Janneke W.C.M. Mulder, Koen F. Dekkers, Thomas B. Kuipers, Leonie C. van Vark-Van der Zee, Monique T. Mulder, Jeanine E. Roeters van Lennep, J. Wouter Jukema, Bastiaan T. Heijmans


  • Open Access

    EPA Induces an Anti-Inflammatory Transcriptome in T Cells, Implicating a Triglyceride-Independent Pathway in Cardiovascular Risk Reduction

    by Nathalie A. Reilly, Koen F. Dekkers, Jeroen Molenaar, Sinthuja Arumugam, Thomas B. Kuipers, Yavuz Ariyurek, Marten A. Hoeksema, J. Wouter Jukema, Bastiaan T. Heijmans


  • Open Access

    Eicosapentaenoic acid induces an anti-inflammatory transcriptomic landscape in T cells implicating a pathway independent of triglyceride lowering in cardiovascular risk reduction

    by Nathalie Amara Reilly, Koen F. Dekkers, Jeroen Molenaar, Sinthuja Arumugam, Thomas B. Kuipers, Yavuz Ariyurek, Marten A. Hoeksema, J. Wouter Jukema, Bastiaan T. Heijmans

    A twice-daily dose of highly purified eicosapentaenoic acid (EPA) reduces the risk of atherosclerotic cardiovascular disease among patients with high triglycerides and either known cardiovascular disease or those at high risk for developing it. However, the process by which EPA exerts its beneficial effects remains poorly understood. Here, we show that EPA can induce an anti-inflammatory transcriptional profile in non-activated CD4 + T cells. We find that EPA-exposed CD4 + T cells downregulate immune response related genes, such as HLA-DRA, CD69 , and IL2RA , while upregulating genes involved in oxidative stress prevention, such as NQO1 . Furthermore, transcription footprint analysis based on ATAC-sequencing reveals downregulation of GATA3 and PU.1, key transcription factors in T H 2 and T H 9 differentiation, and upregulation of REV-ERB, an antagonist of T H 17 differentiation. By in parallel examining T cell responses to oleic acid, a monounsaturated fatty acid, and palmitic acid, a saturated fatty acid, we find that both the intensity of the transcriptomic response and the involvement of anti-inflammatory pathways is highly specific for EPA. Thus, EPA can induce an anti-inflammatory transcriptomic landscape in CD4 + T cells, a process that may contribute to the unexpectedly strong beneficial effects of EPA on the risk of atherosclerotic cardiovascular disease in clinical trials.

  • Open Access

    Oleic acid triggers CD4 + T cells to be metabolically rewired and poised to differentiate into proinflammatory T cell subsets upon activation

    by Nathalie A. Reilly, Friederike Sonnet, Koen F. Dekkers, Joanneke C. Kwekkeboom, Lucy Sinke, Stan Hilt, Hayat M. Suleiman, Marten A. Hoeksema, Hailiang Mei, Erik W. van Zwet, et al.

    Summary: T cells are the most common immune cells in atherosclerotic plaques and the function of T cells can be altered by fatty acids. Here, we show that pre-exposure of CD4 + T cells to oleic acid, an abundant fatty acid linked to cardiovascular events, results in a preferential differentiation into pro-inflammatory subsets upon activation by upregulating core metabolic pathways. RNA-sequencing of non-activated CD4 + T cells revealed that oleic acid upregulates genes encoding enzymes responsible for cholesterol and fatty acid biosynthesis. Transcription footprint analysis linked this rewiring to the differentiation of pro-inflammatory subsets. Indeed, spectral flow cytometry showed that pre-exposure to oleic acid results in a skew toward IL-9, IL-17A, IL-5 and IL-13 producing T cells upon activation. Importantly, inhibition of either cholesterol or fatty acid biosynthesis abolishes this effect, suggesting a beneficial role for statins beyond cholesterol lowering. Taken together, fatty acids may affect inflammatory diseases by influencing T cell metabolism.


  • Effects of fatty acids on T cell function: role in atherosclerosis

    by Nathalie A. Reilly, Esther Lutgens, Johan Kuiper, Bastiaan T. Heijmans, J. Wouter Jukema

    T cells are among the most common cell types present in atherosclerotic plaques and are increasingly being recognized as a central mediator in atherosclerosis development and progression. At the same time, triglycerides and fatty acids have re-emerged as crucial risk factors for atherosclerosis. Triglycerides and fatty acids are important components of the milieu to which the T cell is exposed from the circulation to the plaque, and increasing evidence shows that fatty acids influence T cell function. In this Review, we discuss the effects of fatty acids on four components of the T cell response — metabolism, activation, proliferation and polarization — and the influence of these changes on the pathogenesis of atherosclerosis. We also discuss how quiescent T cells can undergo a type of metabolic reprogramming induced by exposure to fatty acids in the circulation that influences the subsequent functions of T cells after activation, such as in atherosclerotic plaques.